Latent class analysis identifies functional decline with Amsterdam IADL in preclinical Alzheimer's disease.

Alzheimer's disease Amsterdam-IADL Autonomy Latent class analysis Linear mixed model

Journal

Alzheimer's & dementia (New York, N. Y.)
ISSN: 2352-8737
Titre abrégé: Alzheimers Dement (N Y)
Pays: United States
ID NLM: 101650118

Informations de publication

Date de publication:
2019
Historique:
entrez: 26 10 2019
pubmed: 28 10 2019
medline: 28 10 2019
Statut: epublish

Résumé

Trials in Alzheimer's disease (AD) now include participants at the earliest stages to prevent further decline. However, the lack of tools sensitive to subtle functional changes in early-stage AD hinders the development of new therapies as it is difficult to prove their clinical relevance. We assessed functional changes over three years in 289 elderly memory complainers from the Investigation of Alzheimer's Predictors in subjective memory complainers cohort using the Amsterdam Instrumental-Activities-of-Daily-Living questionnaire (A-IADL-Q). No overall functional decline related to AD imaging markers was evidenced. However, five distinct classes of A-IADL-Q trajectories were identified. The largest class (212 [73.4%]) had stable A-IADL-Q scores over 3 years. A second group (23 [8.0%]) showed a persistent functional decline, higher amyloid load ( The A-IADL-Q identified a subtle functional decline in asymptomatic at-risk AD individuals. This could have important implications in the field of early intervention in AD.

Identifiants

pubmed: 31650012
doi: 10.1016/j.trci.2019.08.009
pii: S2352-8737(19)30060-5
pmc: PMC6804616
doi:

Types de publication

Journal Article

Langues

eng

Pagination

553-562

Investigateurs

Hovagim Bakardjian (H)
Habib Benali (H)
Hugo Bertin (H)
Joel Bonheur LaurieBoukadida (JB)
Nadia Boukerrou (N)
Enrica Cavedo (E)
Patrizia Chiesa (P)
Olivier Colliot (O)
Bruno Dubois (B)
Marion Dubois (M)
Stéphane Epelbaum (S)
Geoffroy Gagliardi (G)
Remy Genthon (R)
Marie-Odile Habert (MO)
Harald Hampel (H)
Marion Houot (M)
Aurélie Kas (A)
Foudil Lamari (F)
Marcel Levy (M)
Simone Lista (S)
Christiane Metzinger (C)
Fanny Mochel (F)
Francis Nyasse (F)
Catherine Poisson (C)
Marie-Claude Potier (MC)
Marie Revillon (M)
Antonio Santos (A)
Katia Santos Andrade (KS)
Marine Sole (M)
Mohmed Surtee (M)
Michel Thiebaud de Schotten (M)
Andrea Vergallo (A)
Nadjia Younsi (N)

Informations de copyright

© 2019 The Authors.

Références

Alzheimers Res Ther. 2015 Mar 18;7(1):17
pubmed: 25815063
Gerontologist. 1969 Autumn;9(3):179-86
pubmed: 5349366
Int J Alzheimers Dis. 2011;2011:276734
pubmed: 21660245
Ann Neurol. 2012 Jun;71(6):765-75
pubmed: 22488240
Neurodegener Dis Manag. 2012 Oct 1;2(5):483-491
pubmed: 23585777
J Geriatr Psychiatry Neurol. 2013 Dec;26(4):244-50
pubmed: 24212244
CMAJ. 1997 Oct 15;157(8):1037-45
pubmed: 9347774
Comput Methods Programs Biomed. 2005 May;78(2):165-73
pubmed: 15848271
Curr Neurol Neurosci Rep. 2017 Mar;17(3):27
pubmed: 28283961
Neuroepidemiology. 2013;41(1):35-41
pubmed: 23712106
J Am Geriatr Soc. 2011 Dec;59(12):2273-81
pubmed: 22188074
Alzheimers Dement (N Y). 2015 Sep 1;1(2):103-110
pubmed: 26451386
BMJ Open. 2019 Feb 19;8(12):e021017
pubmed: 30782589
Alzheimers Dement. 2012 Nov;8(6):536-43
pubmed: 23102123
Gerontologist. 2009 Dec;49(6):767-77
pubmed: 19506030
Alzheimer Dis Assoc Disord. 2007 Apr-Jun;21(2):122-9
pubmed: 17545737
Curr Alzheimer Res. 2018;15(13):1261-1266
pubmed: 30251604
Lancet Neurol. 2018 Apr;17(4):335-346
pubmed: 29500152
Alzheimers Dement (Amst). 2017 Mar 31;8:26-35
pubmed: 28462387
J Alzheimers Dis. 2018;64(s1):S3-S22
pubmed: 29562511
Age Ageing. 2018 Nov 1;47(6):764-768
pubmed: 30165372
J Alzheimers Dis. 2017;58(2):425-434
pubmed: 28453478
Neurology. 2018 Apr 10;90(15):695-703
pubmed: 29592885
Lancet Neurol. 2010 Nov;9(11):1118-27
pubmed: 20934914
J Gerontol A Biol Sci Med Sci. 2016 Mar;71(3):391-7
pubmed: 26419979
Dement Geriatr Cogn Disord. 2010;30(2):147-54
pubmed: 20733307
J Am Geriatr Soc. 2008 Jan;56(1):37-44
pubmed: 18028344
Alzheimers Dement. 2015 Oct;11(10):1231-40
pubmed: 25598195
Alzheimers Dement. 2018 Jun;14(6):837-842
pubmed: 29604264
Psychol Aging. 2013 Dec;28(4):1070-5
pubmed: 24364409
Neurology. 1988 Jun;38(6):900-3
pubmed: 3368071
J Gen Intern Med. 2002 Oct;17(10):766-73
pubmed: 12390552

Auteurs

Sarah-Christine Villeneuve (SC)

Institute of Memory and Alzheimer's Disease (IM2A), Department of Neurology, Center of excellence of neurodegenerative disease (CoEN) and National Reference Center for Rare or Early Dementias Pitié-Salpêtrière Hospital, AP-HP, Boulevard de l'hôpital, Paris, France.
Department of Geriatry, Hôpital Maisonneuve-Rosemont, Montréal, QC, Canada.

Marion Houot (M)

Institute of Memory and Alzheimer's Disease (IM2A), Department of Neurology, Center of excellence of neurodegenerative disease (CoEN) and National Reference Center for Rare or Early Dementias Pitié-Salpêtrière Hospital, AP-HP, Boulevard de l'hôpital, Paris, France.

Federica Cacciamani (F)

Institut du Cerveau et de la Moelle épinière, ICM, Paris, France.
Inserm, U 1127, Paris, France.
CNRS, UMR 7225, Paris, France.
Sorbonne Université, Paris, France.
Inria, Aramis project-team, Paris, France.

Merike Verrijp (M)

Department of Neurology, Alzheimer Center Amsterdam, Amsterdam Neuroscience, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands.

Bruno Dubois (B)

Institute of Memory and Alzheimer's Disease (IM2A), Department of Neurology, Center of excellence of neurodegenerative disease (CoEN) and National Reference Center for Rare or Early Dementias Pitié-Salpêtrière Hospital, AP-HP, Boulevard de l'hôpital, Paris, France.
Institut du Cerveau et de la Moelle épinière, ICM, Paris, France.
Inserm, U 1127, Paris, France.
CNRS, UMR 7225, Paris, France.
Sorbonne Université, Paris, France.

Sietske Sikkes (S)

Department of Neurology, Alzheimer Center Amsterdam, Amsterdam Neuroscience, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands.
Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.

Stéphane Epelbaum (S)

Institute of Memory and Alzheimer's Disease (IM2A), Department of Neurology, Center of excellence of neurodegenerative disease (CoEN) and National Reference Center for Rare or Early Dementias Pitié-Salpêtrière Hospital, AP-HP, Boulevard de l'hôpital, Paris, France.
Institut du Cerveau et de la Moelle épinière, ICM, Paris, France.
Inserm, U 1127, Paris, France.
CNRS, UMR 7225, Paris, France.
Sorbonne Université, Paris, France.
Inria, Aramis project-team, Paris, France.

Classifications MeSH